SwePub
Sök i LIBRIS databas

  Extended search

(WFRF:(Bickeböller Heike))
 

Search: (WFRF:(Bickeböller Heike)) > (2020-2024) > Impact of individua...

  • Wang, XinanDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Harvard University, 667 Huntington Ave, MA, Boston, United States (author)

Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification

  • Article/chapterEnglish2024

Publisher, publication year, extent ...

  • BioMed Central (BMC),2024
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:umu-221118
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-221118URI
  • https://doi.org/10.1186/s13073-024-01298-4DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Background: Although polygenic risk score (PRS) has emerged as a promising tool for predicting cancer risk from genome-wide association studies (GWAS), the individual-level accuracy of lung cancer PRS and the extent to which its impact on subsequent clinical applications remains largely unexplored.Methods: Lung cancer PRSs and confidence/credible interval (CI) were constructed using two statistical approaches for each individual: (1) the weighted sum of 16 GWAS-derived significant SNP loci and the CI through the bootstrapping method (PRS-16-CV) and (2) LDpred2 and the CI through posteriors sampling (PRS-Bayes), among 17,166 lung cancer cases and 12,894 controls with European ancestry from the International Lung Cancer Consortium. Individuals were classified into different genetic risk subgroups based on the relationship between their own PRS mean/PRS CI and the population level threshold.Results: Considerable variances in PRS point estimates at the individual level were observed for both methods, with an average standard deviation (s.d.) of 0.12 for PRS-16-CV and a much larger s.d. of 0.88 for PRS-Bayes. Using PRS-16-CV, only 25.0% of individuals with PRS point estimates in the lowest decile of PRS and 16.8% in the highest decile have their entire 95% CI fully contained in the lowest and highest decile, respectively, while PRS-Bayes was unable to find any eligible individuals. Only 19% of the individuals were concordantly identified as having high genetic risk (> 90th percentile) using the two PRS estimators. An increased relative risk of lung cancer comparing the highest PRS percentile to the lowest was observed when taking the CI into account (OR = 2.73, 95% CI: 2.12–3.50, P-value = 4.13 × 10−15) compared to using PRS-16-CV mean (OR = 2.23, 95% CI: 1.99–2.49, P-value = 5.70 × 10−46). Improved risk prediction performance with higher AUC was consistently observed in individuals identified by PRS-16-CV CI, and the best performance was achieved by incorporating age, gender, and detailed smoking pack-years (AUC: 0.73, 95% CI = 0.72–0.74). Conclusions: Lung cancer PRS estimates using different methods have modest correlations at the individual level, highlighting the importance of considering individual-level uncertainty when evaluating the practical utility of PRS.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Zhang, ZiweiDepartment of Medical Oncology, Dana-Farber Cancer Institute, MA, Boston, United States (author)
  • Ding, YiBioinformatics Interdepartmental Program, University of California, Los Angeles, United States (author)
  • Chen, TonyDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Harvard University, MA, Boston, United States (author)
  • Mucci, LoreleiDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, MA, Boston, United States (author)
  • Albanes, DemetriosDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, MD, Bethesda, United States (author)
  • Landi, Maria TeresaDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, MD, Bethesda, United States (author)
  • Caporaso, Neil E.Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, MD, Bethesda, United States (author)
  • Lam, StephenDepartment of Medicine, British Columbia Cancer Agency, University of British Columbia, Vancouver, Canada (author)
  • Tardon, AdoninaFaculty of Medicine, University of Oviedo and CIBERESP, Oviedo, Spain (author)
  • Chen, ChuDepartment of Epidemiology, University of Washington School of Public Health, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, WA, Seattle, United States (author)
  • Bojesen, Stig E.Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark (author)
  • Johansson, MattiasGenomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France (author)
  • Risch, AngelaDepartment of Biosciences and Medical Biology, Allergy-Cancer-BioNano Research Centre, University of Salzburg, and Cancer Cluster Salzburg, Salzburg, Austria (author)
  • Bickeböller, HeikeDepartment of Genetic Epidemiology, University Medical Center, Georg August University Göttingen, Göttingen, Germany (author)
  • Wichmann, H-ErichInstitute of Medical Informatics, Biometry and Epidemiology, Ludwig Maximilians University, Munich, Germany (author)
  • Rennert, GadiClalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Carmel, Haifa, Israel (author)
  • Arnold, SusanneMarkey Cancer Center, University of Kentucky, KY, Lexington, United States (author)
  • Brennan, PaulGenomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France (author)
  • McKay, James D.Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France (author)
  • Field, John K.Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom (author)
  • Shete, Sanjay S.Department of Biostatistics, The University of Texas MD Anderson Cancer Center, TX, Houston, United States (author)
  • Le Marchand, LoicEpidemiology Program, University of Hawaii Cancer Center, HI, Honolulu, United States (author)
  • Liu, GeoffreyPrincess Margaret Cancer Centre, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada (author)
  • Andrew, Angeline S.Department of Epidemiology, Department of Community and Family Medicine, Dartmouth Geisel School of Medicine, NH, Hanover, United States (author)
  • Kiemeney, Lambertus A.Department for Health Evidence, Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands (author)
  • Zienolddiny-Narui, ShanNational Institute of Occupational Health, Oslo, Norway (author)
  • Behndig, Annelie F.,1963-Umeå universitet,Institutionen för folkhälsa och klinisk medicin(Swepub:umu)anbe0145 (author)
  • Johansson, MikaelUmeå universitet,Institutionen för strålningsvetenskaper(Swepub:umu)mijo0025 (author)
  • Cox, AngieDepartment of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, United Kingdom (author)
  • Lazarus, PhilipDepartment of Pharmaceutical Sciences, College of Pharmacy, Washington State University, WA, Spokane, United States (author)
  • Schabath, Matthew B.Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, FL, Tampa, United States (author)
  • Aldrich, Melinda C.Department of Medicine, Department of Biomedical Informatics and Department of Thoracic Surgery, Vanderbilt University Medical Center, TN, Nashville, United States (author)
  • Hung, Rayjean J.Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Dalla Lana School of Public Health, University of Toronto, ON, Toronto, Canada (author)
  • Amos, Christopher I.Institute for Clinical and Translational Research, Department of Medicine, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, TX, Houston, United States (author)
  • Lin, XihongDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Harvard University, MA, Boston, United States (author)
  • Christiani, David C.Department of Environmental Health, Harvard T.H. Chan School of Public Health, Harvard University, 667 Huntington Ave, MA, Boston, United States; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, MA, Boston, United States (author)
  • Department of Environmental Health, Harvard T.H. Chan School of Public Health, Harvard University, 667 Huntington Ave, MA, Boston, United StatesDepartment of Medical Oncology, Dana-Farber Cancer Institute, MA, Boston, United States (creator_code:org_t)

Related titles

  • In:Genome Medicine: BioMed Central (BMC)16:11756-994X

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view